4th January 2017
Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")
Top Ten Equity Holdings and Sector and Geographic Exposure as at 30th December 2016 and full Portfolio listing as at 30th November 2016 available from company's website
Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 30th December 2016 the top ten equity holdings and the sector and geographic breakdown were as follows:
Top 10 Holdings |
% |
Pfizer |
7.6% |
Merck & Co |
7.3% |
Johnson & Johnson |
6.2% |
Sanofi |
5.0% |
GlaxoSmithKline |
5.0% |
Roche |
4.6% |
Astellas Pharma |
4.0% |
Novartis |
3.6% |
Merck KGaA |
3.5% |
Teva Pharmaceutical Industries |
3.0% |
Total |
49.9% |
Sector Exposure |
% |
Pharmaceuticals |
61.3% |
Healthcare Equipment |
9.9% |
Biotechnology |
9.4% |
Healthcare REITs |
5.7% |
Healthcare Services |
4.8% |
Healthcare Facilities |
3.6% |
Managed Healthcare |
2.1% |
Healthcare Supplies |
0.9% |
Life & Health Insurance |
0.6% |
Life Sciences Tools & Services |
0.6% |
Healthcare Distributors |
0.2% |
Cash |
1.0% |
Total |
100.0% |
Geographic Exposure |
% |
United States |
50.7% |
United Kingdom |
11.2% |
Switzerland |
8.8% |
Japan |
6.0% |
France |
5.0% |
Germany |
4.1% |
Israel |
3.0% |
Australia |
3.0% |
Ireland |
2.7% |
Canada |
2.0% |
India |
0.7% |
Italy |
0.7% |
Denmark |
0.6% |
Norway |
0.4% |
Cash |
1.0% |
Total |
100% |
The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager. www.Polarcapitalhealthcaretrust.com
Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.